Donor-Cell Origin High-Risk Myelodysplastic Syndrome Synchronous with an Intracranial Meningioma-Like Tumor, 8 Years after Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Lymphocytic Leukemia
Secondary neoplasias are well known consequences of radiotherapy or chemotherapy for a primary cancer. In this report, we describe two rare secondary neoplasias occurring in the same patient: a meningioma-like intracranial tumor and high-risk myelodysplastic syndrome (MDS) of donor-cells origin, bot...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2017-01-01
|
| Series: | Case Reports in Medicine |
| Online Access: | http://dx.doi.org/10.1155/2017/9674385 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850175184420470784 |
|---|---|
| author | G. Brás C. Pinho-Vaz A. Campos |
| author_facet | G. Brás C. Pinho-Vaz A. Campos |
| author_sort | G. Brás |
| collection | DOAJ |
| description | Secondary neoplasias are well known consequences of radiotherapy or chemotherapy for a primary cancer. In this report, we describe two rare secondary neoplasias occurring in the same patient: a meningioma-like intracranial tumor and high-risk myelodysplastic syndrome (MDS) of donor-cells origin, both diagnosed simultaneously, 8 years after an allogeneic hematopoietic stem cell transplantation (allo-HSCT) for chronic lymphocytic leukemia (CLL). Due to an engraftment failure during the first allo-HSCT of a matched related donor for CLL treatment, the salvage treatment was a second allo-HSCT. At the moment of meningioma-like tumor diagnosis, the patient was pancytopenic due to high-risk MDS, so it was decided to postpone a surgical intervention until hematological improvement. For the high-risk MDS of donor-cells origin the chosen treatment was induction with intensive chemotherapy. Due to refractory disease, the patient was treated with 5-azacitidine and donor-lymphocytes infusion with no response and, finally, a third allo-HSCT of a matched unrelated donor was performed. The patient died 6 months after the third allo-HSCT, in cytogenetic remission but without hematological recovery, due to an intracranial hemorrhage with origin in the meningioma-like tumor. |
| format | Article |
| id | doaj-art-cf0b30a45d4b4b92b63599a255dda80f |
| institution | OA Journals |
| issn | 1687-9627 1687-9635 |
| language | English |
| publishDate | 2017-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Case Reports in Medicine |
| spelling | doaj-art-cf0b30a45d4b4b92b63599a255dda80f2025-08-20T02:19:30ZengWileyCase Reports in Medicine1687-96271687-96352017-01-01201710.1155/2017/96743859674385Donor-Cell Origin High-Risk Myelodysplastic Syndrome Synchronous with an Intracranial Meningioma-Like Tumor, 8 Years after Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Lymphocytic LeukemiaG. Brás0C. Pinho-Vaz1A. Campos2Serviço de Transplante de Medula Óssea, Instituto Português de Oncologia do Porto, Porto, PortugalServiço de Transplante de Medula Óssea, Instituto Português de Oncologia do Porto, Porto, PortugalServiço de Transplante de Medula Óssea, Instituto Português de Oncologia do Porto, Porto, PortugalSecondary neoplasias are well known consequences of radiotherapy or chemotherapy for a primary cancer. In this report, we describe two rare secondary neoplasias occurring in the same patient: a meningioma-like intracranial tumor and high-risk myelodysplastic syndrome (MDS) of donor-cells origin, both diagnosed simultaneously, 8 years after an allogeneic hematopoietic stem cell transplantation (allo-HSCT) for chronic lymphocytic leukemia (CLL). Due to an engraftment failure during the first allo-HSCT of a matched related donor for CLL treatment, the salvage treatment was a second allo-HSCT. At the moment of meningioma-like tumor diagnosis, the patient was pancytopenic due to high-risk MDS, so it was decided to postpone a surgical intervention until hematological improvement. For the high-risk MDS of donor-cells origin the chosen treatment was induction with intensive chemotherapy. Due to refractory disease, the patient was treated with 5-azacitidine and donor-lymphocytes infusion with no response and, finally, a third allo-HSCT of a matched unrelated donor was performed. The patient died 6 months after the third allo-HSCT, in cytogenetic remission but without hematological recovery, due to an intracranial hemorrhage with origin in the meningioma-like tumor.http://dx.doi.org/10.1155/2017/9674385 |
| spellingShingle | G. Brás C. Pinho-Vaz A. Campos Donor-Cell Origin High-Risk Myelodysplastic Syndrome Synchronous with an Intracranial Meningioma-Like Tumor, 8 Years after Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Lymphocytic Leukemia Case Reports in Medicine |
| title | Donor-Cell Origin High-Risk Myelodysplastic Syndrome Synchronous with an Intracranial Meningioma-Like Tumor, 8 Years after Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Lymphocytic Leukemia |
| title_full | Donor-Cell Origin High-Risk Myelodysplastic Syndrome Synchronous with an Intracranial Meningioma-Like Tumor, 8 Years after Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Lymphocytic Leukemia |
| title_fullStr | Donor-Cell Origin High-Risk Myelodysplastic Syndrome Synchronous with an Intracranial Meningioma-Like Tumor, 8 Years after Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Lymphocytic Leukemia |
| title_full_unstemmed | Donor-Cell Origin High-Risk Myelodysplastic Syndrome Synchronous with an Intracranial Meningioma-Like Tumor, 8 Years after Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Lymphocytic Leukemia |
| title_short | Donor-Cell Origin High-Risk Myelodysplastic Syndrome Synchronous with an Intracranial Meningioma-Like Tumor, 8 Years after Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Lymphocytic Leukemia |
| title_sort | donor cell origin high risk myelodysplastic syndrome synchronous with an intracranial meningioma like tumor 8 years after allogeneic hematopoietic stem cell transplantation for chronic lymphocytic leukemia |
| url | http://dx.doi.org/10.1155/2017/9674385 |
| work_keys_str_mv | AT gbras donorcelloriginhighriskmyelodysplasticsyndromesynchronouswithanintracranialmeningiomaliketumor8yearsafterallogeneichematopoieticstemcelltransplantationforchroniclymphocyticleukemia AT cpinhovaz donorcelloriginhighriskmyelodysplasticsyndromesynchronouswithanintracranialmeningiomaliketumor8yearsafterallogeneichematopoieticstemcelltransplantationforchroniclymphocyticleukemia AT acampos donorcelloriginhighriskmyelodysplasticsyndromesynchronouswithanintracranialmeningiomaliketumor8yearsafterallogeneichematopoieticstemcelltransplantationforchroniclymphocyticleukemia |